No Data
DocGo to Announce Third Quarter 2024 Results on Thursday, November 7, 2024
DocGo Inc (DCGO) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions
Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years
Stifel Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $6.5
Analysts' Top Healthcare Picks: DocGo (DCGO), Avidity Biosciences (RNA)
Express News | DocGo Inc - Steven Katz Resigns as Chair of DocGo Board